COM:CORCEPT
Corcept Therapeutics
- Stock
Last Close
55.92
22/11 21:00
Market Cap
3.19B
Beta: -
Volume Today
648.55K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -46.01M - | -31.38M 31.79% | -6.41M 79.58% | 8.14M 227.03% | 129.12M 1,486.27% | 75.41M 41.60% | 94.18M 24.89% | 106.01M 12.56% | 112.51M 6.13% | 101.42M 9.86% | 106.14M 4.66% | |
depreciation and amortization | 74K - | 141K 90.54% | 155K 9.93% | 87K 43.87% | 106K 21.84% | 236K 122.64% | 2.17M 819.92% | 2.24M 3.04% | 3.07M 37.10% | 2.97M 3.20% | 2.36M 20.44% | |
deferred income tax | -76.70M - | 14.07M 118.34% | 16.88M 19.98% | 14.09M 16.52% | 4.35M 69.15% | -33.91M 880.14% | -29.49M 13.01% | |||||
stock based compensation | 5.20M - | 5.20M 0.10% | 6.01M 15.61% | 7.06M 17.38% | 13.36M 89.30% | 23.75M 77.73% | 29.31M 23.44% | 33.54M 14.42% | 42.93M 28.00% | 42.44M 1.14% | 48.94M 15.31% | |
change in working capital | -762K - | -5.04M 561.68% | 500K 109.92% | 1.16M 131.20% | -5.71M 594.29% | 3.93M 168.71% | -4.69M 219.38% | -5.36M 14.29% | -57K 98.94% | 6.02M 10,654.39% | 8.22M 36.60% | |
accounts receivables | -871K - | -1.91M 118.83% | -2.89M 51.47% | -3.64M 26.05% | -5.44M 49.49% | -2.29M 57.94% | -2.34M 2.27% | -6.27M 167.95% | -1.43M 77.24% | -3.43M 140.50% | -10.07M 193.30% | |
inventory | -883K - | 249K 128.20% | 815K 227.31% | -682K 183.68% | -2.26M 231.67% | -7.78M 243.90% | -1.04M 86.58% | -3.51M 236.59% | 3.44M 198.01% | 1.20M 65.19% | 1.26M 5.50% | |
accounts payables | -1.42M - | -495K 65.21% | -561K 13.33% | 965K 272.01% | 6.29M 551.71% | -389K 106.19% | -735K 88.95% | 3.16M 530.07% | -3.60M 213.79% | 4.76M 232.25% | 5.78M 21.46% | |
other working capital | 2.42M - | -2.89M 219.67% | 3.13M 208.41% | 4.51M 44.02% | -4.30M 195.32% | 14.38M 434.39% | -568K 103.95% | 1.27M 322.89% | 1.52M 20.30% | 3.49M 129.28% | 11.24M 221.91% | |
other non cash items | 4.45M - | 3.71M 16.60% | 2.87M 22.58% | 1.95M 32.06% | 763K 60.87% | -1.72M 325.56% | -1.74M 0.99% | 1.45M 183.49% | 5.09M 251.00% | 1.38M 72.85% | -9.13M 760.01% | |
net cash provided by operating activities | -37.06M - | -27.38M 26.13% | 3.13M 111.43% | 18.39M 487.57% | 60.94M 231.33% | 115.67M 89.82% | 136.12M 17.68% | 151.97M 11.65% | 167.89M 10.48% | 120.32M 28.33% | 127.04M 5.58% | |
investments in property plant and equipment | -127K - | -174K 37.01% | -17K 90.23% | -194K 1,041.18% | -419K 115.98% | -298K 28.88% | -1.09M 265.10% | -1.24M 13.79% | -469K 62.12% | -413K 11.94% | -139K 66.34% | |
acquisitions net | 116.74M - | 118.03M 1.10% | -136.59M 215.73% | 113.91M 183.40% | -91.05M 179.92% | |||||||
purchases of investments | -73.04M - | -233.12M 219.19% | -299.04M 28.27% | -420.11M 40.49% | -312.81M 25.54% | -355.07M 13.51% | -328.75M 7.41% | |||||
sales maturities of investments | 142.66M - | 182.29M 27.79% | 302.09M 65.71% | 449.40M 48.76% | 241.15M 46.34% | 419.79M 74.08% | ||||||
other investing activites | -116.74M - | -118.03M 1.10% | 136.59M 215.73% | -113.91M 183.40% | 91.05M 179.92% | |||||||
net cash used for investing activites | -127K - | -174K 37.01% | -17K 90.23% | -194K 1,041.18% | -73.46M 37,763.92% | -90.77M 23.57% | -117.83M 29.81% | -119.26M 1.22% | 136.13M 214.14% | -114.33M 183.99% | 90.91M 179.51% | |
debt repayment | -1.02M - | -4.86M 373.76% | -9.21M 89.60% | -14.78M 60.52% | -15.13M 2.40% | -1.45M - | -1.69M 16.05% | -2.02M 20.18% | -2.20M 8.59% | |||
common stock issued | 55K - | 8.42M - | 23.23M 175.88% | 16.23M 30.13% | 4.38M 73.01% | 5.81M 32.64% | ||||||
common stock repurchased | -23.66M - | -30.98M 30.93% | -9.95M 67.89% | -295.99M 2,876.22% | -21.66M 92.68% | -145.43M 571.26% | ||||||
dividends paid | -6.97M - | -21.54M 209.19% | -14.20M 34.06% | -23.86M 68.01% | ||||||||
other financing activites | 1.78M - | 22.28M 1,153.85% | 7.68M 65.52% | 7.18M 6.53% | 9.32M 29.81% | 2.33M 75.01% | 22.16M 851.03% | -6.61M 129.81% | 26.06M 494.54% | -9.11M 134.94% | ||
net cash used provided by financing activities | -970K - | -3.08M 217.42% | 13.07M 524.62% | -7.10M 154.28% | -7.95M 12.08% | -14.34M 80.25% | -28.64M 99.83% | 12.21M 142.64% | -302.59M 2,577.41% | -17.28M 94.29% | -148.72M 760.47% | |
effect of forex changes on cash | ||||||||||||
net change in cash | -38.16M - | -30.63M 19.72% | 16.19M 152.85% | 11.10M 31.42% | -20.47M 284.43% | 10.56M 151.59% | -10.36M 198.04% | 44.92M 533.77% | 1.43M 96.82% | -11.29M 891.03% | 69.22M 713.24% | |
cash at beginning of period | 93.03M - | 54.88M 41.01% | 24.25M 55.81% | 40.44M 66.76% | 51.54M 27.45% | 31.06M 39.73% | 41.63M 34.01% | 31.27M 24.88% | 76.19M 143.66% | 77.62M 1.87% | 66.33M 14.54% | |
cash at end of period | 54.88M - | 24.25M 55.81% | 40.44M 66.76% | 51.54M 27.45% | 31.06M 39.73% | 41.63M 34.01% | 31.27M 24.88% | 76.19M 143.66% | 77.62M 1.87% | 66.33M 14.54% | 135.55M 104.36% | |
operating cash flow | -37.06M - | -27.38M 26.13% | 3.13M 111.43% | 18.39M 487.57% | 60.94M 231.33% | 115.67M 89.82% | 136.12M 17.68% | 151.97M 11.65% | 167.89M 10.48% | 120.32M 28.33% | 127.04M 5.58% | |
capital expenditure | -127K - | -174K 37.01% | -17K 90.23% | -194K 1,041.18% | -419K 115.98% | -298K 28.88% | -1.09M 265.10% | -1.24M 13.79% | -469K 62.12% | -413K 11.94% | -139K 66.34% | |
free cash flow | -37.19M - | -27.55M 25.91% | 3.11M 111.30% | 18.20M 484.55% | 60.52M 232.56% | 115.37M 90.64% | 135.03M 17.04% | 150.73M 11.63% | 167.42M 11.07% | 119.91M 28.38% | 126.90M 5.83% |
All numbers in (except ratios and percentages)